Zhen Chen
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Immunogenicity and Safety of Two-dose Schedules With Different Intervals of an ORF7-deficient Live Vaccine Candidate for Varicella: A Randomized, Double-blind, Controlled, Phase 2b Trial.
Journal: The Pediatric infectious disease journal
Published: February 18, 2026
Immunogenicity and safety of an ORF7-deficient skin-attenuated and neuro-attenuated live vaccine for varicella: a randomised, double-blind, controlled, phase 2a trial.
Journal: The Lancet. Infectious diseases
Published: December 03, 2023
Safety and immunogenicity of a skin- and neuro-attenuated live vaccine for varicella: a randomized, double-blind, controlled, dose-escalation and age de-escalation phase 1 clinical trial.
Journal: The Lancet regional health. Western Pacific
Published: December 04, 2022
Safety and immunogenicity of a protein subunit COVID-19 vaccine (ZF2001) in healthy children and adolescents aged 3-17 years in China: a randomised, double-blind, placebo-controlled, phase 1 trial and an open-label, non-randomised, non-inferiority, phase 2 trial.
Journal: The Lancet. Child & adolescent health
Published: October 19, 2022
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial.
Journal: The Lancet. Infectious diseases
Published: November 18, 2020
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial.
Journal: The Lancet. Infectious diseases
Published: September 14, 2020
Safety, immunogenicity, and lot-to-lot consistency of live attenuated varicella vaccine in 1-3 years old children: a double-blind, randomized phase III trial.
Journal: Human vaccines & immunotherapeutics
Published: November 28, 2018
Evaluation of Varicella-zoster virus-specific cell-mediated immunity by interferon-γ Enzyme-Linked Immunosorbent Assay in adults ≥50 years of age administered a herpes zoster vaccine.
Journal: Journal of medical virology
Published: November 07, 2018
Efficacy, safety and immunogenicity of live attenuated varicella vaccine in healthy children in China: double-blind, randomized, placebo-controlled clinical trial.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: July 17, 2018
Sequence Analysis and Comparison of the Key Genes of Domestic Live Attenuated Varicella Vaccine.
Journal: Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae
Published: November 11, 2017
Optimal Allocation of Node Capacity in Cascade-Robustness Networks.
Journal: PloS one
Published: August 27, 2015
Showing 1-12 of 12
Last Updated: 09/26/2026